WARSAW, Ind.,
Jan. 16,
2025 /PRNewswire/ -- Zimmer Biomet Holdings,
Inc. (NYSE and SIX: ZBH) today announced its fourth quarter
earnings conference call will be webcast on Thursday, February 6, 2025 at 8:30 a.m. ET. A news release detailing the
quarterly results will be made available that day at 6:30 a.m. ET.
The live audio webcast can be accessed via Zimmer Biomet's
Investor Relations website at
https://investor.zimmerbiomet.com. It will be available for
replay following the conference call.
Individuals in the U.S. and Canada who wish to dial into the conference
call may do so by dialing (888) 204-4368 and using conference ID
5103691. International callers should dial +1 (323) 994-2093
and use conference ID 5103691.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a
comprehensive portfolio designed to maximize mobility and improve
health. We seamlessly transform the patient experience through our
innovative products and suite of integrated digital and robotic
technologies that leverage data, data analytics and artificial
intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow on LinkedIn
at www.linkedin.com/company/zimmerbiomet or X / Twitter
at www.twitter.com/zimmerbiomet.
Media
|
|
Investors
|
|
Heather
Zoumas-Lubeski
(445)
248-0577
heather.zoumaslubeski@zimmerbiomet.com
|
|
David
DeMartino
(646)
531-6115
david.demartino@zimmerbiomet.com
Zach Weiner
(908)
591-6955
zach.weiner@zimmerbiomet.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-webcast-and-conference-call-of-fourth-quarter-2024-financial-results-302352253.html
SOURCE Zimmer Biomet Holdings, Inc.